Showing results (1731-1740 of 13,047) with videos related to
Sort By:
Pageof 1,305
Clinical Rehabilitation|April 15, 2021
A qualitative study exploring the implementation determinants of rehabilitation and global wellness programs for orchestral musiciansMarianne Roos, Jean-Sébastien Roy, Marie-Eve LamontagneThe Journal of Orthopaedic and Sports Physical Therapy|September 11, 2012
A 12-week exercise therapy program in middle-aged patients with degenerative meniscus tears: a case series with 1-year follow-upSilje Stensrud, Ewa M Roos, May Arna RisbergThe South African Journal of Physiotherapy|August 25, 2020
Predictors for the academic success of first-year physiotherapy students at a South African universitySfiso Mabizela, Ronel Roos, Hellen Myezwa, et al.Journal of Rehabilitation Research and Development|January 25, 2014
Sampling frequency impacts measurement of walking activity after strokeBrian Knarr, Margaret A Roos, Darcy S ReismanThe Plant Journal : for Cell and Molecular Biology|February 3, 2015
Susceptibility to Verticillium longisporum is linked to monoterpene production by TPS23/27 in ArabidopsisJonas Roos, Sarosh Bejai, Raimondas Mozūraitis, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|July 4, 2014
Specific genomic aberrations predict survival, but low mutation rate in cancer hot spots, in clear cell renal cell carcinomaLinda Köhn, Ulrika Svenson, Börje Ljungberg, et al.The Plant Cell|February 12, 2015
"Self" and "non-self" in the control of phytoalexin biosynthesis: plant phospholipases A2 with alkaloid-specific molecular fingerprintsMichael Heinze, Wolfgang Brandt, Sylvestre Marillonnet, et al.Leber, Magen, Darm|January 1, 1985
[Endotube as a palliative measure in stenosing cancer of the esophagus and cardia]G Buess, B Kometz, H Schellong, et al.Genes, Chromosomes & Cancer|February 1, 1993
DNA fingerprinting of renal cell carcinoma with special reference to tumor heterogeneityC Mehle, B Ljungberg, R Stenling, et al.European Journal of Neurology|May 23, 2020
Interleukin-1 receptor antagonist, interleukin-2 receptor alpha subunit and amyotrophic lateral sclerosisS Yuan, P M Roos, S C LarssonPageof 1,305